{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T19:45:52Z","timestamp":1791834352597,"version":"4.3.4"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Identifying a donor for facial vascularized composite allotransplant recipients can be a lengthy, emotionally challenging process. Little is known about the relative distribution of key donor characteristics among potential donors. Data on actual wait times of patients are limited, making it difficult to estimate wait times for future recipients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>The authors retrospectively reviewed charts of nine facial vascularized composite allotransplant patients and provide data on transplant wait times and patient characteristics. In addition, they analyzed the United Network for Organ Sharing database of dead organ donors. After excluding donors with high-risk characteristics (e.g., active cancer or risk factors for blood-borne disease transmission), the authors calculated the distribution of relevant donor-recipient matching criteria (i.e., ethnicity, body mass index, age, ABO blood group, cytomegalovirus, Epstein-Barr virus, hepatitis C virus) among 65,201 potential donors.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The median wait time for a transplant was 4 months (range, 1 day to 17 months). The large majority of United Network for Organ Sharing\u2013recorded deaths from disease were white (63 percent) and male (58 percent). Female donors of black, Hispanic, or Asian descent are underrepresented, with 7, 5, and 1 percent of all recorded deaths from disease, respectively. Potential donors show cytomegalovirus and Epstein-Barr virus seropositivity of 65 and 95 percent, respectively. The number of annual hepatitis C\u2013positive donors increased over time.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Actual facial vascularized composite allotransplant wait times vary considerably. Although most patients experience acceptable wait times, some with underrepresented characteristics exceed acceptable levels. Cytomegalovirus-seropositive donors present a large portion of the donor pool, and exclusion for seronegative patients may increase wait time. Hepatitis C\u2013seropositive donors may constitute a donor pool for underrepresented patient groups in the future.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/prs.0000000000008094","type":"journal-article","created":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T20:03:29Z","timestamp":1624910609000},"page":"194-202","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Donor and Recipient Matching in Facial Vascularized Composite Allotransplantation: A Closer Look at the Donor Pool"],"prefix":"10.1097","volume":"148","author":[{"given":"Martin","family":"Kauke","sequence":"first","affiliation":[{"name":"From the Division of Plastic Surgery, Department of Surgery, Brigham and Women\u2019s Hospital, Harvard Medical School; and the Department of Hand, Plastic and Reconstructive Surgery, Microsurgery, Burn Trauma Center, BG Trauma Center Ludwigshafen, University of Heidelberg."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"Haug","sequence":"additional","affiliation":[{"name":"From the Division of Plastic Surgery, Department of Surgery, Brigham and Women\u2019s Hospital, Harvard Medical School; and the Department of Hand, Plastic and Reconstructive Surgery, Microsurgery, Burn Trauma Center, BG Trauma Center Ludwigshafen, University of Heidelberg."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doha","family":"Obed","sequence":"additional","affiliation":[{"name":"From the Division of Plastic Surgery, Department of Surgery, Brigham and Women\u2019s Hospital, Harvard Medical School; and the Department of Hand, Plastic and Reconstructive Surgery, Microsurgery, Burn Trauma Center, BG Trauma Center Ludwigshafen, University of Heidelberg."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick","family":"Diehm","sequence":"additional","affiliation":[{"name":"From the Division of Plastic Surgery, Department of Surgery, Brigham and Women\u2019s Hospital, Harvard Medical School; and the Department of Hand, Plastic and Reconstructive Surgery, Microsurgery, Burn Trauma Center, BG Trauma Center Ludwigshafen, University of Heidelberg."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianief","family":"Tchiloemba","sequence":"additional","affiliation":[{"name":"From the Division of Plastic Surgery, Department of Surgery, Brigham and Women\u2019s Hospital, Harvard Medical School; and the Department of Hand, Plastic and Reconstructive Surgery, Microsurgery, Burn Trauma Center, BG Trauma Center Ludwigshafen, University of Heidelberg."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali-Farid","family":"Safi","sequence":"additional","affiliation":[{"name":"From the Division of Plastic Surgery, Department of Surgery, Brigham and Women\u2019s Hospital, Harvard Medical School; and the Department of Hand, Plastic and Reconstructive Surgery, Microsurgery, Burn Trauma Center, BG Trauma Center Ludwigshafen, University of Heidelberg."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bohdan","family":"Pomahac","sequence":"additional","affiliation":[{"name":"From the Division of Plastic Surgery, Department of Surgery, Brigham and Women\u2019s Hospital, Harvard Medical School; and the Department of Hand, Plastic and Reconstructive Surgery, Microsurgery, Burn Trauma Center, BG Trauma Center Ludwigshafen, University of Heidelberg."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,6,29]]},"reference":[{"key":"R1-20250501","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1097\/TP.0000000000003171","article-title":"Mucosa and rejection in facial vascularized composite allotransplantation: A systematic review.","volume":"104","author":"Kauke","year":"2020","journal-title":"Transplantation"},{"key":"R2-20250501","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1056\/NEJMoa1111432","article-title":"Three patients with full facial transplantation.","volume":"366","author":"Pomahac","year":"2012","journal-title":"N Engl J Med"},{"key":"R3-20250501","doi-asserted-by":"crossref","first-page":"e3038","DOI":"10.1097\/GOX.0000000000003038","article-title":"Partial loss of nasal tissue in a facial vascularized composite allograft patient.","volume":"8","author":"Kauke","year":"2020","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"R4-20250501","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/MOT.0000000000000140","article-title":"Acute rejection in vascularized composite allotransplantation.","volume":"19","author":"Fischer","year":"2014","journal-title":"Curr Opin Organ Transplant"},{"key":"R6-20250501","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1080\/23723505.2016.1189992","article-title":"A single center\u2019s experience with donation of facial allografts for transplantation.","volume":"2","author":"Huang","year":"2015","journal-title":"Vascularized Compos Allotransplant"},{"key":"R7-20250501","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1097\/PRS.0b013e318208d03c","article-title":"Cytomegalovirus and other infectious issues related to face transplantation: Specific considerations, lessons learned, and future recommendations.","volume":"127","author":"Gordon","year":"2011","journal-title":"Plast Reconstr Surg"},{"key":"R8-20250501","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1097\/PRS.0b013e3181ee482d","article-title":"Institutional review board-based recommendations for medical institutions pursuing protocol approval for facial transplantation.","volume":"126","author":"Siemionow","year":"2010","journal-title":"Plast Reconstr Surg"},{"key":"R9-20250501","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1111\/ajt.14381","article-title":"The American Society of Transplantation Consensus Conference on the use of hepatitis C viremic donors in solid organ transplantation.","volume":"17","author":"Levitsky","year":"2017","journal-title":"Am J Transplant"},{"key":"R10-20250501","doi-asserted-by":"crossref","first-page":"e0158431","DOI":"10.1371\/journal.pone.0158431","article-title":"Efficacy and safety of direct acting antivirals in kidney transplant recipients with chronic hepatitis C virus infection.","volume":"11","author":"Lin","year":"2016","journal-title":"PLoS One"},{"issue":"Suppl","key":"R11-20250501","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/ajt.15678","article-title":"OPTN\/SRTR 2018 annual data report: Deceased organ donation.","volume":"20","author":"Israni","year":"2020","journal-title":"Am J Transplant"},{"key":"R12-20250501","doi-asserted-by":"crossref","first-page":"e1833","DOI":"10.1097\/GOX.0000000000001833","article-title":"Prevalence and distribution of potential vascularized composite allotransplant donors, implications for optimizing the donor-recipient match.","volume":"6","author":"Mendenhall","year":"2018","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"R13-20250501","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/ndt\/gfr306","article-title":"Impact of CMV infection on acute rejection and long-term renal allograft function: A systematic analysis in patients with protocol biopsies and indicated biopsies.","volume":"27","author":"Erdbruegger","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R14-20250501","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1086\/324516","article-title":"Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir.","volume":"184","author":"Razonable","year":"2001","journal-title":"J Infect Dis"},{"key":"R15-20250501","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1034\/j.1600-6143.2002.20907.x","article-title":"The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients.","volume":"2","author":"Sagedal","year":"2002","journal-title":"Am J Transplant"},{"key":"R16-20250501","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/ajt.12013","article-title":"Infections following facial composite tissue allotransplantation: Single center experience and review of the literature.","volume":"13","author":"Knoll","year":"2013","journal-title":"Am J Transplant"},{"key":"R17-20250501","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1093\/ndt\/gfr769","article-title":"Impact of Epstein-Barr virus donor and recipient serostatus on the incidence of post-transplant lymphoproliferative disorder in kidney transplant recipients.","volume":"27","author":"Sampaio","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R18-20250501","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/micr.30272","article-title":"Face allotransplantation for various types of facial disfigurements: A series of five cases.","volume":"38","author":"\u00d6zkan","year":"2018","journal-title":"Microsurgery"},{"key":"R19-20250501","doi-asserted-by":"crossref","first-page":"e13598","DOI":"10.1111\/ctr.13598","article-title":"Use of HCV Ab+\/NAT- donors in HCV na\u00efve renal transplant recipients to expand the kidney donor pool.","volume":"33","author":"Dao","year":"2019","journal-title":"Clin Transplant"},{"key":"R20-20250501","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/MOT.0000000000000724","article-title":"Latest developments in living kidney donation.","volume":"25","author":"Hilbrands","year":"2020","journal-title":"Curr Opin Organ Transplant"},{"key":"R21-20250501","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1055\/s-0039-3401466","article-title":"Indian subcontinent\u2019s first bilateral supracondylar level upper limb transplantation.","volume":"52","author":"Sharma","year":"2019","journal-title":"Indian J Plast Surg"},{"key":"R22-20250501","doi-asserted-by":"crossref","first-page":"e283","DOI":"10.1016\/j.bjps.2009.08.013","article-title":"Simulated central face transplantation: Age consideration in matching donors and recipients.","volume":"63","author":"Aflaki","year":"2010","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R23-20250501","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/MOT.0000000000000742","article-title":"Kidney transplantation following uncontrolled donation after circulatory death.","volume":"25","author":"Summers","year":"2020","journal-title":"Curr Opin Organ Transplant"},{"key":"R24-20250501","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/lt.24666","article-title":"Successful donation after cardiac death liver transplants with prolonged warm ischemia time using normothermic regional perfusion.","volume":"23","author":"De Carlis","year":"2017","journal-title":"Liver Transpl"},{"key":"R25-20250501","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1001\/archsurg.2011.240","article-title":"Liver transplantation using organ donation after cardiac death: A clinical predictive index for graft failure-free survival.","volume":"146","author":"Hong","year":"2011","journal-title":"Arch Surg"},{"key":"R26-20250501","doi-asserted-by":"crossref","first-page":"e260","DOI":"10.1097\/TP.0000000000003221","article-title":"Hypothermic ex situ perfusion of human limbs with acellular solution for 24 hours.","volume":"104","author":"Haug","year":"2020","journal-title":"Transplantation"},{"key":"R27-20250501","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1111\/ajt.14386","article-title":"Utilization of organs from donors according to hepatitis C antibody and nucleic acid testing status: Time for change.","volume":"17","author":"Kling","year":"2017","journal-title":"Am J Transplant"},{"key":"R28-20250501","doi-asserted-by":"crossref","first-page":"273","DOI":"10.7326\/M18-0749","article-title":"Twelve-month outcomes after transplant of hepatitis C-infected kidneys into uninfected recipients: A single-group trial.","volume":"169","author":"Reese","year":"2018","journal-title":"Ann Intern Med"},{"key":"R29-20250501","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1177\/003335491312800403","article-title":"PHS guideline for reducing human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission through organ transplantation.","volume":"128","author":"Seem","year":"2013","journal-title":"Public Health Rep"},{"key":"R30-20250501","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/jocs.12861","article-title":"Heart transplant outcomes in recipients of Centers for Disease Control (CDC) high risk donors.","volume":"31","author":"Tsiouris","year":"2016","journal-title":"J Card Surg"},{"key":"R31-20250501","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1002\/hep.30540","article-title":"Increasing utilization and excellent initial outcomes following liver transplant of hepatitis C virus (HCV)-viremic donors into HCV-negative recipients: Outcomes following liver transplant of HCV-viremic donors.","volume":"69","author":"Cotter","year":"2019","journal-title":"Hepatology"},{"key":"R32-20250501","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1056\/NEJMoa1812406","article-title":"Heart and lung transplants from HCV-infected donors to uninfected recipients.","volume":"380","author":"Woolley","year":"2019","journal-title":"N Engl J Med"},{"key":"R33-20250501","doi-asserted-by":"crossref","first-page":"e140","DOI":"10.1097\/TP.0000000000003093","article-title":"Successful HIV-positive, live renal donor transplant: A unique method of expanding the donor pool.","volume":"104","author":"Kapuriya","year":"2020","journal-title":"Transplantation"},{"key":"R34-20250501","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/j.1600-6143.2011.03506.x","article-title":"Estimating the potential pool of HIV-infected deceased organ donors in the United States: Estimating the potential pool of HIV-infected deceased organ donors.","volume":"11","author":"Boyarsky","year":"2011","journal-title":"Am J Transplant"}],"container-title":["Plastic &amp; Reconstructive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PRS.0000000000008094","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:18:42Z","timestamp":1746145122000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PRS.0000000000008094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,29]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/prs.0000000000008094","relation":{},"ISSN":["0032-1052"],"issn-type":[{"value":"0032-1052","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6,29]]}}}